PROZ / Public programme / Zürich

Events

Free public talks that bring current psychedelic research into the room.

Our upcoming talk

20.10.26

Sebastian William Foster

Set, Setting, and Statute: A Legal Journey through Psychedelic Prohibition, Human Rights, and the Rule of Law

Sebastian William Foster

About the talk

People have sought out psychedelic experiences for thousands of years, from ancient rock art and sacred ceremonies to the laboratories of modern medicine. So how did these substances end up among the most tightly prohibited in the world?

This talk follows that journey. Beginning in deep history, we move through the political and legal developments of the twentieth century, when psychedelic prohibition became embedded in the international drug-control system. From there, we enter the courtroom, where human rights arguments are putting that prohibition to the test under South Africa’s progressive Constitution. Finally, we reach the heart of the matter — a growing disconnect between what the law says these substances are and what they truly appear to be. In this ever-growing disconnect, what happens to the law’s legitimacy?

In psychedelic research, set and setting refer to the mindset and surroundings that shape an experience. On 20 October, we will explore a third influence: statute — the laws behind the criminalisation of psychedelics

Time and venue

Tuesday, October 20, 2026
18:30
Universität Zürich · HAH-E-03, Häldeliweg 2, 8044 Zürich

Sebastian William Foster — Set, Setting, and Statute: A Legal Journey through Psychedelic Prohibition, Human Rights, and the Rule of Law — 2026-10-20

Also this autumn

03.11.26 Dr. Johannes JungwirthTitle to be announced
Dr. Johannes Jungwirth

About the talk

Title and abstract to be announced.

Time and venue

Venue to be announced!

Save the date · time and venue to follow.

Portrait source: Psychiatric University Hospital Zurich ↗

17.11.26 Prof. Dr. Linda SimmlerChanging synaptic strength: Psychedelics and their role in neuroplasticity
Prof. Dr. Linda Simmler

About the talk

A public lecture in English with Prof. Dr. Linda Simmler on psychedelics and their role in neuroplasticity. A 45-minute talk followed by 15 minutes of audience questions. Free admission. Full abstract to follow.

Time and venue

18:30 · Universität Zürich · HAH-E-03, Häldeliweg 2, 8044 Zürich

Prof. Dr. Linda Simmler — Changing synaptic strength: Psychedelics and their role in neuroplasticity — 2026-11-17

Portrait source: University of Basel ↗

01.12.26 PD Dr. med. Milan ScheideggerFrom Molecules to Medicines: Inside Psychedelic Drug Development
PD Dr. med. Milan Scheidegger

About the talk

How does a promising psychedelic compound become a treatment patients can benefit from? This lecture offers a behind-the-scenes perspective on psychedelic drug development, exploring the scientific questions and practical decisions that connect laboratory discoveries with clinical care. Drawing on his translational research with DMT-based formulations, Milan Scheidegger discusses the interplay between pharmacology and therapeutic context, alongside key clinical and regulatory challenges. At the intersection of neuroscience, psychiatry and biotechnology, the talk examines the opportunities and open questions on the path towards approved psychedelic treatments.

Time and venue

18:30 · Universität Zürich · HAH-E-03, Häldeliweg 2, 8044 Zürich

PD Dr. med. Milan Scheidegger — From Molecules to Medicines: Inside Psychedelic Drug Development — 2026-12-01

Portrait source: Milan Scheidegger ↗

Earlier programme

Past talks

06.10.26 Are the Ethical Challenges of Psychedelic-Assisted Therapy Exceptional?PD Dr. Dr. Daniel Villiger

About the talk

Psychedelic-assisted therapy is often portrayed as exceptional because of psychedelics’ unusual features. This talk asks whether those features justify exceptional normative treatment and examines four prominent areas of debate: informed consent, therapists’ personal psychedelic experience, clinical trial design, and heightened patient vulnerability. I argue that while three of these presumed cases of psychedelic exceptionalism are either not exceptional after all or not sufficiently justified, enhanced vulnerability during psychedelic sessions may require genuinely distinctive safeguards.

About Daniel

PD Dr. Dr. Daniel Villiger is a philosopher and postdoctoral researcher at the University of Zurich. His research spans decision theory, rationality, bioethics, and cognitive science; his habilitation examined philosophical issues in psychedelic-assisted therapy.

University of Zurich · speaker profile ↗

Time and venue

18:30–19:30 · Universität Zürich · HAH-E-03, Häldeliweg 2, 8044 Zürich

PD Dr. Dr. Daniel Villiger — Are the Ethical Challenges of Psychedelic-Assisted Therapy Exceptional? — 2026-10-06
22.09.26 From Renaissance to ConfluenceDr. Adana Omágua-Kambeba

About the talk

How can psychedelic science build more reciprocal relationships with the Indigenous communities whose knowledge has helped shape the field? Through the concept of Cosmic Diplomacy, Adana Omágua-Kambeba explores dialogue between Indigenous and Western sciences grounded in respect and intercultural collaboration.

The talk considers partnerships among Indigenous communities, universities, health professionals, and the pharmaceutical industry. Confluence invites different knowledge traditions to meet while retaining their distinct perspectives, with shared responsibility for people, territories, and the future of health.

About Adana

Dr. Adana Omágua-Kambeba is a physician and knowledge keeper of the Omágua-Kambeba people of the Brazilian Amazon. She studied medicine at the Universidade Federal de Minas Gerais. Her work connects Indigenous medicine, Western science, and intercultural dialogue, approaching health through relationships with community, territory, plants, and ancestors.

Tera Kuno’s programme ↗

Time and venue

19:00–20:30 · KOL-F-101 · UZH Main Building

Watch the recording →
Dr. Adana Omágua-Kambeba — From Renaissance to Confluence — 2026-09-22
31.03.26 Clinical pharmacology of classical psychedelicsFriederike Holze

About the talk

Classic psychedelics and entactogens are promising candidates for treating psychiatric and neurological disorders, driving renewed research into their pharmacology, mechanisms, and safety. This talk examines dosing, comparative effects, pharmacokinetics, interactions, and implications for individualized treatment.

Time and venue

18:30–19:30 · HAH-E-03 · Häldeliweg 2, Zürich

Watch the recording →
14.04.26 Difficulties following naturalistic psychedelic use and associations with adverse childhood experiencesMichelle Olofsson

About the talk

Michelle Olofsson presents large-scale survey work on psychedelic-related difficulties: what people report, how long challenges last, and which factors may predict them. The lecture gives particular attention to adverse childhood experiences as a potential vulnerability factor and concludes with implications for harm reduction and clinical research.

Time and venue

18:30–19:30 · HAH-E-03 · Häldeliweg 2, Zürich

Watch the recording →
22.04.26 Transdiagnostic Effects and Mechanisms of PAT: Clinical Insights from Our Patient CohortSusanne Prinz

About the talk

This talk looks beyond symptom reduction to ask how psychedelic-assisted therapy may change the way people relate to themselves, emotions, other people, and the world. Clinical data, case vignettes, and real-world observations illustrate connectedness, emotional access, meaning-making, and psychological flexibility.

Time and venue

18:30–19:30 · KOL-F-101 · UZH Main Building

Watch the recording →
28.04.26 Psychedelics and Self-TranscendenceKurt Stocker

About the talk

Kurt Stocker presents a phenomenologically grounded model derived from more than 100 hours of interviews in controlled LSD and DMT studies. The model asks whether self-transcendence is best understood as loss of identity, or as a more nuanced reorganization in which aspects of minimal self remain identifiable.

Time and venue

18:30–19:30 · KOL-F-101 · UZH Main Building

06.05.26 The Afterglow Phenomenon Following the Use of Classic PsychedelicsTomislav Majic

About the talk

What stays after a psychedelic experience ends? Psychiatrist and researcher Tomislav Majic examines the transient period of improved mood, well-being, and cognitive flexibility often called the afterglow, how it is studied, and what part it may play in therapeutic outcomes.

Time and venue

18:30–19:30 · HAH-E-03 · Häldeliweg 2, Zürich

12.05.26 Death and Sacred KnowledgeWilliam Richards

About the talk

William Richards reflects on altered states of consciousness, palliative care, and the religious dimensions of healing. Drawing on decades of clinical research and psychotherapy, the lecture considers consciousness, suffering, meaning, and care at the end of life.

Time and venue

18:30–19:30 · HAH-E-03 · Häldeliweg 2, Zürich

Watch the recording →
19.05.26 Psychedelics and CreativityDila Suay

About the talk

Dila Suay brings historical and neuroscientific perspectives together with controlled DMT/harmine research to examine divergent thinking, convergent thinking, artistic expression, and the broader phenomenology of creative processes.

Time and venue

18:30–19:30 · HAH-E-03 · Häldeliweg 2, Zürich

Watch the recording →

After the room

Keep watching

When recording is possible, talks join the public lecture archive.